HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine Medical Countermeasures February 18, 2020 …
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics Medical Countermeasures February 18, 2020 …
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development Antimicrobial Resistance February 7, 2020 …
HHS, Regeneron Collaborate to Develop COVID-19 Treatment Using VelociSuite Technology Medical Countermeasures February 4, 2020 …
Seqirus’ Pandemic Flu Vaccine Approved: Next Generation Technology Strengthens Preparedness Medical Countermeasures February 3, 2020 …
BARDA Seeks Input from Suppliers on Potential SARS-CoV-2 Medical Countermeasures Contracts + Grants February 2, 2020 …
Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections Antimicrobial Resistance November 25, 2019 …
Diagnosing Sepsis in Minutes: Cytovale Raises $15 Million in Financing Biodetection November 9, 2019 …
Debiopharm Progresses in Their Stand Against Drug-Resistant N. gonorrhoeae Antimicrobial Resistance November 8, 2019 …
Bavarian Nordic Announces Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine Medical Countermeasures October 10, 2019 …
BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract Contracts + Grants September 26, 2019 …
20 Years of the Strategic National Stockpile: Response History Timeline Medical Countermeasures August 25, 2019 …
Detecting Infection Before Symptoms Occur by Monitoring the Vagus Nerve Biosurveillance August 1, 2019 …
BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine Contracts + Grants August 1, 2019 …
In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures Contracts + Grants June 18, 2019 …
